Previously treated cases tested for RR-/MDR-TB in Serbia

Serbia: Previously treated cases tested for RR-/MDR-TB was 48.0% in 2024. ▼ Falling

Latest (2024)
48.0%
Change on year
up 128.6%
World rank
153rd
of 180 countries
All-time high
67.0%
in 2019
All-time low
21.0%
in 2023
Years of data
17
2005–2024

Previously treated cases tested for RR-/MDR-TB in Serbia, 2005–2024

2030405060702005201420242005: 402006: 422007: 592008: 462010: 562011: 622012: 462013: 622014: 372015: 282016: 292017: 272018: 402019: 672022: 322023: 212024: 48

Source: World Health Organization, Global Health Observatory.

Analysis

The most recent figure for previously treated cases tested for rr-/mdr-tb in Serbia is 48.0%, measured in 2024.

Compared with earlier readings it is up 128.6% on the previous year and up 29.7% over ten years.

Over the whole period, previously treated cases tested for rr-/mdr-tb in Serbia peaked at 67.0% in 2019 and was at its lowest, 21.0%, in 2023.

Serbia ranks 153rd of 180 countries on this measure, in the bottom quarter.

The long-run direction has been consistently falling across the 17 years of available data.

Previously treated cases tested for RR-/MDR-TB in Serbia, year by year

Annual values for Previously treated cases tested for RR-/MDR-TB (%) in Serbia, 2005 to 2024.
Year Value Change
2005 40.0%
2006 42.0% +5.0%
2007 59.0% +40.5%
2008 46.0% -22.0%
2010 56.0% +21.7%
2011 62.0% +10.7%
2012 46.0% -25.8%
2013 62.0% +34.8%
2014 37.0% -40.3%
2015 28.0% -24.3%
2016 29.0% +3.6%
2017 27.0% -6.9%
2018 40.0% +48.1%
2019 67.0% +67.5%
2022 32.0% -52.2%
2023 21.0% -34.4%
2024 48.0% +128.6%

Averages by decade

DecadeAverage LowestHighest Years
2000s 46.8% 40.0% 59.0% 4
2010s 45.4% 27.0% 67.0% 10
2020s 33.7% 21.0% 48.0% 3

Countries ranked near Serbia

  1. 150 Sweden 50.0% compare
  2. 151 Portugal 49.0% compare
  3. 151 Singapore 49.0% compare
  4. 153 Switzerland 48.0% compare
  5. 155 Malaysia 43.0% compare
  6. 156 Italy 36.0% compare

See the full ranking of 192 places →

More health data for Serbia

All data for Serbia →

Frequently asked questions

What is previously treated cases tested for rr-/mdr-tb in Serbia?
Previously treated cases tested for rr-/mdr-tb in Serbia was 48.0% in 2024, according to World Health Organization, Global Health Observatory.
What is the highest previously treated cases tested for rr-/mdr-tb recorded in Serbia?
The highest recorded value was 67.0% in 2019.
What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Serbia?
The lowest recorded value was 21.0% in 2023.
How does Serbia rank for previously treated cases tested for rr-/mdr-tb?
Serbia ranks 153rd out of 180 countries with data for 2024.
Is previously treated cases tested for rr-/mdr-tb rising or falling in Serbia?
Over the last ten years it is up 29.7%. The long-run trend across the full record is falling.
Where does this Serbia data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 17 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Previously treated cases tested for RR-/MDR-TB in Serbia. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 26 August 2026, from https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/serbia/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/serbia/">Previously treated cases tested for RR-/MDR-TB in Serbia</a> — Statizoid

About this data

Indicator
Previously treated cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
192 places, 3,071 data points, 2005–2024
Last refreshed